HCG Kolkata Combines Immunotherapy and Bone Marrow Transplant to Treat Multiple Myeloma

HCG Kolkata announced the launch of a treatment regimen that pairs immunotherapy with bone‑marrow transplantation for patients diagnosed with multiple myeloma. The hospital says the dual approach is intended to harness the immune system’s ability to target cancer cells while providing a refreshed marrow environment to sustain remission. Multiple myeloma, a cancer of plasma cells in the bone marrow, has traditionally been managed with chemotherapy, targeted drugs, and single‑modality transplants. By integrating immunotherapy, clinicians aim to improve response rates and reduce relapse risk. HCG Kolkata officials indicated that the protocol is now available to eligible patients at the facility, marking a step forward in the city’s oncology services.